Donald Trump announced that he has ordered the Department of Defense to immediately resume testing U.S. nuclear weapons “on an equal basis” with Russia and China. He made the announcement via social media shortly before meeting Xi Jinping in South Korea, highlighting perceived advancements in Russia and China’s nuclear programs as a major motivating factor.
The U.S. has not conducted a full nuclear weapons test since 1992, and while no other major power publicly has either in recent decades, Trump’s directive signals a sharp shift away from longstanding U.S. policy and the global moratorium on explosive nuclear testing. Trump’s statement did not clarify whether “testing” refers to full-scale warhead detonations, delivery systems, or simulations — adding uncertainty to how the directive will be implemented and what the exact scope of “immediate” action entails.
Reactions were swift both domestically and abroad. Experts and critics warned that restarting nuclear tests could undermine arms-control treaties, accelerate a new arms race, and weaken global non-proliferation efforts. Foreign counterparts, including China’s government, reiterated calls for adherence to non-proliferation norms and expressed concern over the U.S. decision.
The timing of the announcement — on the eve of high-level diplomatic talks with China — underscores the domestic and international strategic stakes. While Trump framed the directive as a response to competitor actions and a demonstration of U.S. military strength, the move also raises broader questions about U.S. security strategy, alliances, arms-control frameworks, and the potential for unintended escalation. The coming days will likely see clarification on the specific testing program, responses from adversaries, and implications for global nuclear dynamics.
